Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1-Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients

被引：1

作者：

Bill, Marius ^{[1
]}

Eckardt, Jan-Niklas ^{[1
]}

Rausch, Christian ^{[2
]}

Metzeler, Klaus H. ^{[3
]}

Spiekermann, Karsten ^{[4
]}

Stasik, Sebastian ^{[5
]}

Sauer, Tim ^{[6
]}

Scholl, Sebastian ^{[7
]}

Hochhaus, Andreas ^{[8
]}

Crysandt, Martina ^{[9
,10
]}

Bruemmendorf, Tim H. ^{[10
]}

Krug, Utz ^{[11
]}

Woermann, Bernhard ^{[12
]}

Hiddemann, Wolfgang

Goerlich, Dennis ^{[13
]}

Sauerland, Maria Cristina ^{[13
]}

Steffen, Bjoern ^{[14
]}

Einsele, Hermann ^{[15
]}

Neubauer, Andreas ^{[16
]}

Burchert, Andreas ^{[17
]}

Schaefer-Eckart, Kerstin ^{[18
]}

Berdel, Wolfgang E. ^{[19
]}

Schliemann, Christoph ^{[20
]}

Krause, Stefan W. ^{[21
]}

Hanel, Mathias ^{[22
]}

Hanoun, Maher ^{[23
]}

Kaufmann, Martin ^{[24
]}

Fransecky, Lars ^{[25
]}

Braess, Jan ^{[26
]}

Ruhnke, Leo ^{[27
]}

Schetelig, Johannes ^{[28
,29
]}

Middeke, Jan Moritz ^{[1
]}

Serve, Hubert ^{[30
]}

Baldus, Claudia D. ^{[31
]}

Platzbecker, Uwe ^{[32
]}

Mueller-Tidow, Carsten

Bornhaeuser, Martin

Herold, Tobias ^{[33
]}

Thiede, Christian ^{[5
]}

Roellig, Christoph ^{[27
]}

机构：

[1] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 1, Dresden, Germany

[2] Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Med 3, Lab Leukemia Diagnost, Munich, Germany

[3] Univ Leipzig, Med Ctr, Dept Hematol Cellular Therapy Hemostaseol & Infec, Leipzig, Germany

[4] Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Med 3, Munich, Germany

[5] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 1, Dresden, Germany

[6] Heidelberg Univ Hosp, Heidelberg, Germany

[7] Jena Univ Hosp, Klin Innere Med 2, Jena, Germany

[8] Klin Innere Med II, Dept Hematol & Oncol, Jena, Germany

[9] Univ Hosp RWTH Aachen, Dept Hematol & Oncol, Aachen, Germany

[10] Ctr Integrated Oncol Aachen Bonn Cologne Duesseld, Aachen, Germany

[11] Hosp Leverkusen, Dept Med 3, Leverkusen, Germany

[12] Charite, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany

[13] Univ Munster, Inst Biostat & Clin Res, Munster, Germany

[14] Univ Hosp Frankfurt, Dept Hematol & Oncol, Frankfurt, Germany

[15] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany

[16] Phillips Univ Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany

[17] Univ Klinikum Giessen & Marburg, Hamatol Onkol & Immunol, Marburg, Germany

[18] BMT Unit, Med Clin 2, Nurnberg, Germany

[19] Univ Hosp Muenster, Dept Med Hematol & Oncol A, Munster, Germany

[20] Univ Hosp Muenster, Dept Med Hematol Oncol & Pneumol A, Munster, Germany

[21] Univ Klinikum Erlangen, Erlangen, Germany

[22] Klinikum Chemnitz, Dept Internal Med 3, Chemnitz, Germany

[23] Univ Hosp Essen, Dept Hematol, Essen, Germany

[24] Robert Bosch Krankenhaus, Dept Hematol Oncol & Palliat Care, Stuttgart, Germany

[25] Univ Hosp Schleswig Holstein Campus Kiel, Dept Internal Med Hematol Oncol 2, Kiel, Germany

[26] Hosp Barmherzige Brueder Regensburg, Regensburg, Germany

[27] Univ Hosp Dresden, Dept Internal Med 1, Dresden, Germany

[28] Tech Univ Dresden, Dresden, Germany

[29] DKMS Grp gGmbH, Dresden, Germany

[30] Goethe Univ Hosp Frankfurt, Dept Internal Med Hematol & Oncol 2, Frankfurt, Germany

[31] Univ Hosp Schleswig Holstein, Dept Hematol & Oncol, Campus Kiel, Kiel, Germany

[32] Univ Leipzig, Med Ctr, Leipzig, Germany

[33] Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Med 3, Munich, Germany

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-186160

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：6

共 50 条

[31] Clonal Hematopoiesis and Its Implications for Flow Cytometric Assessment of Measurable Residual Disease in Patients with NPM1-mutated Acute Myeloid Leukemia
Loghavi, Sanam
DiNardo, Courtney D.
Takahashi, Koichi
Kanagal-Shamanna, Rashmi
Tanaka, Tomoyuki
Furudate, Ken
Short, Nicholas J.
Kadia, Tapan M.
Konopleva, Marina
Farnoud, Noushin
Pierce, Sherry A.
Khoury, Joseph D.
Jorgensen, Jeffrey L.
Patel, Keyur P.
Medeiros, L. Jeffrey
Kantarjian, Hagop M.
Ravandi, Farhad
Wang, Sa A.
BLOOD, 2020, 136
[32] Correlation of NPM1 Type A Mutation Burden With Clinical Status and Outcomes in Acute Myeloid Leukemia Patients With Mutated NPM1 Type A
Jo, Su Yeon
Park, Sang Hyuk
Kim, In-Suk
Yi, Jongyoun
Kim, Hyung-Hoi
Chang, Chulhun L.
Lee, Eun Yup
Cho, Young-Uk
Jang, Seongsoo
Park, Chan-Jeoung
Chi, Hyun-Sook
ANNALS OF LABORATORY MEDICINE, 2016, 36 (05) : 399 - 404
[33] Prognostic Impact of Nucleophosmin 1 (NPM1) Gene Mutations in Egyptian Acute Myeloid Leukemia Patients
Zidan, Magda
Shaaban, Howyda
El Ghannam, Doaa
TURKISH JOURNAL OF HEMATOLOGY, 2013, 30 (02) : 129 - 136
[34] Genetic biomarkers identify a subgroup of high-risk patients within low-risk NPM1-mutated acute myeloid leukemia
Carbonell, Diego
Suarez-Gonzalez, Julia
Chicano, Maria
Andres-Zayas, Cristina
Diez-Diez, Miriam
Rodriguez-Macias, Gabriela
Muniz, Paula
Kwon, Mi
Anguita, Javier
Diez-Martin, Jose Luis
Buno, Ismael
Martinez-Laperche, Carolina
LEUKEMIA & LYMPHOMA, 2021, 62 (05) : 1178 - 1186
[35] Outcomes of patients with nucleoplasmin 1 (NPM1) mutated acute myeloid leukemia (AML) treated with hypomethylating agents (HMAs).
Swaminathan, Mahesh
Jabbour, Elias
Ravandi, Farhad
Kadia, Tapan M.
Borthakur, Gautam
Konopleva, Marina
Dinardo, Courtney Denton
Pierce, Sherry
Alvarado, Yesid
Assi, Rita Elias
Abou Dalle, Iman Adib
Tallis, Eran
Kantarjian, Hagop M.
Garcia-Manero, Guillermo
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[36] Molecular relapse after first-line intensive therapy in patients with CBF or NPM1-mutated acute myeloid leukemia - a FILO study
Orvain, Corentin
Bertoli, Sarah
Peterlin, Pierre
Desbrosses, Yohann
Dumas, Pierre-Yves
Iat, Alexandre
Carre, Martin
Tavernier, Emmanuelle
Riou, Jeremie
Bouvier, Anne
Bidet, Audrey
Tondeur, Sylvie
Renosi, Florian
Mozziconacci, Marie-Joelle
Flandrin-Gresta, Pascale
Dadone-Montaudie, Berengere
Delabesse, Eric
Pigneux, Arnaud
Hunault-Berger, Mathilde
Recher, Christian
LEUKEMIA, 2024, 38 (09) : 1949 - 1957
[37] Double trouble or a silver lining? A case report of two patients with NPM1-mutated donor-derived acute myeloid leukemia (AML)
Loh, Joanna Bao Ern
Walker, Patricia
Avery, Sharon
Patil, Sushrut
Spencer, Andrew
Wei, Andrew
Fleming, Shaun
LEUKEMIA & LYMPHOMA, 2021, 62 (02) : 489 - 491
[38] PROGNOSTIC IMPACT OF LEUKOCYTOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MUTATED NPM1 AND FLT3-ITD
Virijevic, M.
Djunic, I.
Novkovic, A.
Tosic, N.
Vidovic, A.
Colovic, N.
Djurasinovic, V.
Suvajdzic-Vukovic, N.
Tomin, D.
HAEMATOLOGICA, 2012, 97 : 508 - 509
[39] COMPLEX KARYOTYPE NOT OTHER CYTOGENETIC ABNORMALITIES AFFECTS POST-TRANSPLANT SURVIVAL OF PATIENTS WITH NPM1-MUTATED ACUTE MYELOID LEUKEMIA: A STUDY FROM THE EBMT ACUTE LEUKEMIA WORKING PARTY
Moukalled, Nour
Labopin, Myriam
Versluis, Jurjen
de latour, Regis Peffault
Blaise, Didier
Salmenniemi, Urpu
Rambaldi, Alessandro
Gedde-Dahl, Tobias
Tholouli, Eleni
Kroeger, Nicolaus
Bourhis, Jean-Henri
Von Dem Borne, Peter
Deconinck, Eric
Forcade, Edouard
Esteve, Jordi
Ciceri, Fabio
Bazarbachi, Ali
Mohty, Mohamad
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 21 - 22
[40] Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
Thiede, Christian
Koch, Sina
Creutzig, Eva
Steudel, Christine
Illmer, Thomas
Schaich, Markus
Ehninger, Gerhard
BLOOD, 2006, 107 (10) : 4011 - 4020

← 1 2 3 4 5 →